Clinical trial

Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression

NCT00655057

Study summary

ClinicalTrials.gov

Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention S-citalopram Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Cognitive behavioral therapy (CBT) Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention TRODAT-1 single photon emission computed tomographic (SPECT) imaging Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-10-01

PhasePHASE2 / PHASE3

Conditions

Depressionverified · MONDO: depressive disorder

Interventions

S-citalopramDRUG

Cognitive behavioral therapy (CBT)BEHAVIORAL

TRODAT-1 single photon emission computed tomographic (SPECT) imagingPROCEDURE

Sponsors & collaborators

University of Pennsylvanialead sponsor

National Institute of Mental Health (NIMH)collaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00655057 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.